›› 2016, Vol. 43 ›› Issue (10): 2768-2774.doi: 10.16431/j.cnki.1671-7236.2016.10.038

Previous Articles     Next Articles

Construction of Specifically Targeted Chimeric Canine Parvovirus DNA Vaccine and Its Efficacy Assessment

WU Zhi1,2, HAO Fu-xing1, WANG Yong-juan1, LIU Yang1, WANG Dong1, XU Zhou1, YUAN Wei-feng3   

  1. 1. Jiangsu Agri-animal Husbandry Vocational College, Taizhou 225300, China;
    2. College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China;
    3. Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, China
  • Received:2016-03-30 Online:2016-10-20 Published:2016-10-28

Abstract:

To design chimeric DNA vaccine targeted to antigen-presenting cells with enhanced efficacy to induce immunization.The plasmid containing the gene encoding the extracelluar domain of canine cytotoxic T-lymphocyte antigen 4(CTLA-4125),was directly fused to the gene fragment for major antigenic epitopes of VP2(VP2228) by molecular engineering technology.The plasmid containing VP2228 alone was also constructed to serve as control and transfection of COS-7 cells with the two resultant plasimds was performed respectively,followed by assay of Western blotting.The mice were immunized with the constructed two plasimds,respectively.After immunization,the antibodies anginst CPV in the immunized mice at different times were measured by HI.The spleen lymphocyte proliferation response was determined by lymphocyte proliferation assay,and the interferon-γ (IFN-γ) expression level of the mouse lymphocytes were measured by ELISA.The eukaryotic expression plasimds of CTLA-4125-VP2228 fusion protein or VP2228 alone were cloned.Western blotting showed that the two recombinant proteins could be expressed.Immunization results showed that the antibody levels in serum of CTLA-4125-VP2228-immunized mice were significantly higher than that of VP2228-immunized mice (P<0.05).The lymphocyte stimulation indexes and secreted IFN-γ levels of the CTLA-4125-VP2228-immunized mice were significantly higher than that of VP2228-immunized mice (P<0.05 and P<0.01),respectively.CTLA-4125-VP2228 chimeric DNA vaccine stimulates strong immune response in mice,making it possible for further exploration into chimeric DNA that target the antigen to APCs.

Key words: canine parvovirus; DNA vaccine; antigen-presenting cells; targeting

CLC Number: